Products

See leaflet

Benzimir®
bendamustine

Indications

  • Chronic lymphocytic leukemia (CLL).
  • Indolent B-cell non-Hodgkin’s lymphoma (NHL).

Presentations

  • 25 mg x 1 vial
  • 100 mg x 1 vial